This study sought to determine the antioxidant activities of African birch leaf, to assess its interaction with key enzymes relevant to type 2 diabetes (α-amylase and α-glucosidase) and to evaluate its effect on acarbose in vitro.
Introduction
Diabetes is a group of metabolic diseases characterized by hyperglycaemia, which results from defects in insulin resistance, insulin secretion and beta cell dysfunction. Of all of the diagnosed cases of diabetes, NIDDM accounts for approximately 90-95%. It has been linked to several risk factors involving lifestyle, such as smoking, obesity, poor diet and physical inactivity. α-Amylase and α-glucosidase are critical enzymes involved in starch hydrolysis and are implicated in the onset of type 2 diabetes (T2D). Pancreatic α-amylase catalyzes the hydrolysis of starch to a mixture of oligosaccharides and disaccharides, while intestinal α-glucosidase breaks down disaccharides and oligosaccharides into glucose which, upon absorption, enters the bloodstream. Degradation of these complex carbohydrates is very fast and may result in an elevated blood glucose level after a meal. Synthetic oral antidiabetic agents such as acarbose and miglitol elicit their therapeutic effects through the inhibition of these enzymes, but their administration is associated with serious side effects and a failure to alleviate diabetic complications. Recently, interest in the use of medicinal plants in the form of traditional medicine has increased all over the world, especially in Africa, due to their cheap cost, availability and effectiveness. Nigeria has a wide range of plant diversity, with great potential of identifying plants of pharmacological relevance. African birch (Anogeissus leiocarpus) (Family: Combretaceae) is a tropical plant with large ecological distribution across Africa. The plant parts (leaf, stem, bark and root) are used in traditional medicine for the treatment of some ailments because they have been reported to possess antimicrobial, hepatoprotective and antioxidant properties.10, 11 A previous study by Etuk and Mohammed revealed a spontaneous decrease in blood glucose levels in alloxan-induced diabetic rats administered African birch extract. However, there is a dearth of information on the possible mechanism by which the plant elicits its antidiabetic effects.
Consequently, we aimed to assess the antioxidant activities and interaction between aqueous African birch leaf extract with key enzymes linked to starch hydrolysis. Additionally, considering the combinatorial usage of traditional plants and synthetic drugs in Nigeria, it is pertinent to evaluate and compare the effects of this plant to acarbose (a known antidiabetic drug) in vitro.
Materials and Methods

Materials
Sample collection
African birch leaf was purchased from local traditional healers at the Erekasan Market in Akure Metropolis of Ondo State, Nigeria. Authentication of the plant was performed by the Crop, Soil and Pest Management (CSP) Department at the Federal University of Technology, Akure (FUTA), Nigeria (Voucher specimen no: FUTA/HB/0112AL1).
Chemicals and reagents
All chemicals and reagents used in this study were of analytical grade, and glass-distilled water was used.
Aqueous extraction of African birch leaf and acarbose
African birch leaf was thoroughly washed under running distilled water, air dried, ground into powder and kept dry in an air-tight container prior to extraction according to the method of Adefegha and Oboh. The sample (5 g) was weighed, soaked in 100 ml of distilled water and left for 24 h. The mixture was filtered after 24 h and the filtrate kept in a refrigerator below 0 °C. The frozen extract solution was recovered as dried extract under pressure of approximately 200-450 mbar at 40 °C. The dried extract was reconstituted in distilled water (1 mg/ml) and used for subsequent analysis. Similarly, a stock concentration of 1 mg/ml acarbose was prepared and later diluted for subsequent use. Determination of total flavonoid content Briefly, 0.5 ml of extract (1 mg/ml) was mixed with 0.5 ml of methanol, 50 μl of 10% AlCl , 50 μl of 1 M potassium acetate and 1.4 ml of water and incubated at room temperature for 30 min.
Absorbance of the reaction mixture was subsequently measured at 415 nm, and total flavonoid content was calculated and expressed as the quercetin equivalent.
Quantification of phenolic compounds by HPLC-DAD
Reverse phase chromatographic analyses were carried out under gradient conditions using a C column (4.6 mm × 150 mm) packed with 5-μm diameter particles; the mobile phase was water containing 1% formic acid (A) and acetonitrile (B), and the composition gradient was as follows: 13% of B until10 min and then changed to obtain 20%, 30%, 50%, 60%, 70%, 20% and10% B at 20, 30, 40, 50, 60, 70 and 80 min, respectively, following the method described by Adefegha et al.,
with slight modifications. African birch extract and the mobile phase were filtered through a 0.45-μm membrane filter (Millipore) and then degassed in an ultrasonic bath prior to use. African birch extract was analyzed at a concentration of 20 mg/ml. The flow rate was 0.7 ml/min, and the injection volume was 40 μl. The wavelengths were 254 nm for gallic acid; 280 nm for catechin and epicatechin; 325 nm for chlorogenic, caffeic and ellagic acids; and 365 nm for quercetin, quercitrin, rutin and kaempferol. All chromatography operations were carried out at ambient temperature and in triplicate.
In vitro antioxidant studies 1,1-Diphenyl-2 picrylhydrazyl free radical scavenging ability
The free radical scavenging ability of the plant extract against DPPH (1,1-diphenyl-2 picrylhydrazyl) was evaluated as described by Gyamfi et al. Briefly, the extracts (0-500 μg/ml) were mixed with 1 ml of 0.4 mM methanolic solution containing DPPH radicals. The mixture was left in the dark for 30 min and absorbance was read at 516 nm. DPPH free radical scavenging ability was subsequently calculated and expressed as a percentage (%). The method of Halliwell and Gutteridge was used to determine the ability of the plant extract to prevent the Fe /H O -induced decomposition of deoxyribose. Extracts (0-347.83 μg/ml) were added to a reaction mixture containing 120 μl of 20 mM deoxyribose, 400 μl of 0.1 M phosphate buffer and 40 μl of 500 μM FeSO , and brought to a final volume of 800 μl with distilled water. The reaction mixture was incubated at 37 °C for 30 min and the reaction stopped by the addition of 0.5 ml of 2.8% trichloroacetic acid. This was followed by the addition of 0.4 ml of 0.6% thiobarbituric acid solution. The tubes were subsequently incubated in boiling water for 20 min and absorbance was measured at 532 nm. The OH radical scavenging ability was subsequently calculated and expressed as a percentage (%).
Fe chelation assay
The Fe chelating ability of the extract was determined using a modified method of Minotti and Aust. One hundred fifty microliters of freshly prepared FeSO (500 μM) was added to a reaction mixture containing 168 μl of 0.1 M Tris-HCl (pH 7.4), 218 μl of saline and the extracts (0-200 μg/ml). The reaction mixture was incubated for 5 min before the addition of 13 μl of 0.25% 1,10-phenanthroline (w/v). Absorbance was subsequently measured at 510 nm in a Jenway UV/Visible spectrophotometer, 6315 series. The Fe chelating ability was calculated and expressed as a percentage (%).
Lipid peroxidation and thiobarbituric acid reactions
Wistar rats were anaesthetized in mild diethyl ether, and the pancreases were excised. Pancreatic tissue was rapidly rinsed in saline, placed on ice and weighed. The tissue was subsequently homogenized in cold saline (1/10 w/v) with approximately 10 up-and-down strokes in a Teflon glass homogenizer. The homogenate was centrifuged for 10 min at 3000× g to yield pellets that were discarded, and low-speed supernatant (Sl) was obtained. The lipid peroxidation assay was carried out using the modified method of Ohkawa et al. Briefly 100 μl of the S1 fraction was mixed with a reaction mixture containing 30 μl of 0.1 M Tris-HCl buffer (pH 7.4), extracts (0-312.50 μg/ml) and 30 μl of 250 μM freshly prepared FeSO . The volume was brought up to 300 μl with distilled water before incubation at 37 °C for 1 h. The color reaction was developed by adding 300 μl of 8.1% sodium dodecyl sulfate to the reaction mixture containing S1. This was subsequently followed by the addition of 600 μl acetic acid/HCl (pH 3.4) and 600 μl of 0.8% thiobarbituric acid. This mixture was incubated at 100 °C for 1 h and absorbance was read at 532 nm. Lipid peroxidation was subsequently calculated as the amount of malondialdehyde (MDA) produced (% of control).
Enzyme inhibition assay
α-Amylase assay α-Amylase activity was determined according to the method described by Worthington. African birch extract (0-0.8 mg/ml) or acarbose (0-80 μg/ml) and 50 μl of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing Hog pancreatic α-amylase (EC 3.2.1.1) (0.5 mg/ml) were incubated at 25 °C for 10 min. Then, 50 μl of 1% starch solution in 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) was added to each tube. The reaction mixtures were incubated at 25 °C for 10 min and stopped with 100 μl dinitrosalicylic acid color reagent. Thereafter, the mixture was incubated in a boiling water bath for 5 min and cooled to room temperature. The reaction mixture was then diluted by adding 1.0 ml distilled water, and absorbance was measured at 540 nm. α-Amylase inhibitory activity was subsequently calculated and expressed as a percentage (%).
α-Glucosidase inhibition assay α-Glucosidase activity was determined by the modified method described by Oboh et al. Fifty microliters of African birch extract (0-0.8 mg/ml) or acarbose (0-80 μg/ml) and 100 μl of αglucosidase solution (1.0 U/ml) in 0.1 M phosphate buffer (pH 6.9) were incubated at 25 °C for 10 min. Then, 50 μl of 5 mM p-nitrophenyl-α-D-glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was added. The mixtures were incubated at 25 °C for 5 min before reading the absorbance at 405 nm. α-Glucosidase inhibitory activity was calculated and expressed as percentage (%) inhibition.
Statistical analysis
The mean values from triplicate experiments were pooled and expressed as the mean ± standard deviation (STD). One-way analysis of variance was used to analyze the results. Tukey's test was used for the post hoc analysis, and the least significance difference (LSD) was carried out.
GraphPad Prism 6 software was used for the analysis. The IC (extract concentration causing 50% enzyme inhibitory/antioxidant activity) values were determined using non-linear regression analysis.
Results
Spectrophotometric and HPLC-DAD analysis of phenolics in African birch extract Table 1 lists the total phenolic contents of African birch leaf. The results show a total phenolic content of 6.87 mg GAE/g and a total flavonoid content of 4.38 mg QUE/g. Furthermore, HPLC-DAD analysis was performed on African birch leaf extract to identify and quantify the presence of phenolic acids and flavonoids ( Figure 5) (3.17 ± 0.06 mg/g), ellagic acid (3.08 ± 0.08 mg/g), gallic acid (2.97 ± 0.07 mg/g), quercitrin (1.36 ± 0.04 mg/g) and caffeic acid (1.14 ± 0.05 mg/g) ( Table 2 ). Antioxidant properties of African birch extract
The free radical scavenging ability of the sample was assessed and the IC values are presented in Table 3 . The results showed that the leaf extract (IC = 348.25 μg/ml) scavenged DPPH.
Additionally, the OH* scavenging ability of the plant sample was determined; the plant extract (IC = 183.14 μg/ml) scavenged OH . In a similar manner, the plant chelated Fe with an IC value of 187.45 μg/ml. Incubation of pancreas homogenates in the presence of Fe caused a significant increase (p < 0.05) in MDA content. However, African birch extract inhibited MDA production with an IC value of 174.00 μg/ml, as presented in Table 3 . Values with asterisk (*) and (**) along the same row are significantly different (p < 0.05).
N.D; Not determined.
α-Amylase and α-glucosidase inhibitory activities
The α-amylase inhibitory properties of acarbose and African birch extract were assessed and are presented in Figure 1 . The results revealed that both acarbose and the leaf extract inhibited αamylase activity in a concentration-dependent manner. Acarbose (IC = 11.77 μg/ml) had a significantly (p < 0.05) higher α-amylase inhibitory effect than African birch extract acarbose on α-amylase inhibitory activities was also investigated (Figure 2) . Combination of the synthetic drug (acarbose) and traditional plant (African birch leaf ) resulted in a significant (p < 0.05) increase in α-amylase inhibitory activity compared with the plant extract only and synthetic drug (acarbose) only. Likewise, the α-glucosidase inhibitory abilities of the plant, acarbose and their combination are presented in Figure 3 , Figure 4 , and IC values are listed in Table 3 . The results revealed that acarbose (IC = 9.05 μg/ml) had significantly (p < 0.05) higher αglucosidase inhibitory activity than African birch extract (IC = 196.35 μg/ml). Additionally, the combination of African birch extract and acarbose (50:50 v/v) did not cause a significant (p > 0.05) change in α-glucosidase inhibitory activity compared with African birch only and acarbose only. Figure 5 . Representative high performance liquid chromatography profile of African birch leaf. Gallic acid (peak 1), catechin (peak 2), chlorogenic acid (peak 3), caffeic acid (peak 3), ellagic acid (peak 5), epicatechin (peak 6), rutin (peak 7), quercitrin (peak 8), quercetin (peak 9) and kaempferol (peak 10).
Discussion
Total phenolic and flavonoid contents One of the most abundant antioxidants in plants is polyphenols, which are widely distributed across several food products such as herbs, vegetables, cereals, olive, dry legumes, chocolate and beverages. In this study, the total phenol content of African birch was lower than that reported in a previous study from our laboratory on Crassocephalum crepidioides leaf, but it had a higher total flavonoid content than that of C. crepidioides. Additionally, the phenolic content of African birch was significantly (p < 0.05) higher than that of Celosia spp, as reported by Molehin et al. Growing scientific evidence suggests that an excess of highly reactive free radicals, largely due to hyperglycaemia, causes oxidative stress, which further elevates the development and progression of diabetic complications. The use of antioxidant supplementation in reducing the level of oxidative stress and in slowing or preventing the development of complications associated with diseases have shown promising therapeutic effects.4, 5, 16, 26 Many synthetic antioxidant components have shown toxic and/or mutagenic effects. Hence, much attention has been given to naturally occurring antioxidants. Numerous plant constituents have shown free radical scavenging or antioxidant activity.14, 23, 24, 26 The free radical scavenging abilities, prevention of iron chelating ability and lipid peroxidation (Table 3 ) exhibited by African birch may be part of the mechanism through which African birch leaf exerts its biological activities, which may be responsible for its use in folkloric medicine as an antidiabetic agent.
Effect of African birch leaf extract on the inhibitory properties of acarbose against αamylase and α-glucosidase activities
The inhibition of α-amylase and α-glucosidase activities by African birch extract suggests the scientific basis for its folkloric use in the management/treatment of diabetes and could be of great importance in the development of a modern therapeutic in the management of T2D.4, 16 Furthermore, chlorogenic acids and quercetin were abundant compared with other phenolics found in African birch leaf. A recent report showed that caffeic and chlorogenic acids are good inhibitors of α-amylase and α-glucosidase activities. Therefore, we suggest that the inhibition of α-amylase and α-glucosidase activities by plants and plant foods may be attributed to their phenolic constituents.23, 27 This agrees with some studies where the inhibition of key enzymes (α-amylase and α-glucosidase) relevant to T2D by plants has been suggested as a therapeutic approach in the management of this disease, and some vital bioactive compounds, including polyphenols, may possess interesting structure-function benefits and promising potential.5, 16
The increased inhibition in α-amylase activity by acarbose and African birch extract when combined (50:50) resulted in an additive effect (Figure 2) , whereas the combination of both acarbose and leaf extract caused a synergistic effect on their inhibition of α-glucosidase in vitro (Figure 4) . The herb-food interaction may have a beneficial effect by increasing drug efficacy or diminishing potential side effects, as this was validated in our results (Figure 2, Figure 4 ). Findings from this study correlate with those from an earlier study by Boath et al., who affirmed that synergies between acarbose and berry extracts in diabetes treatment/management may enhance the hypoglycaemic effect and the inhibition of α-glucosidase activity.
Conclusion
This study reports the antioxidant activities of African birch leaf and the additive actions and synergistic interaction between African birch leaf and acarbose in inhibiting α-amylase and αglucosidase activities, respectively. However, these effects could be attributed to some phenolic components in African birch leaf. 
